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Background: Juvenile idiopathic arthritis (JIA) is an autoimmune, heterogeneous disease and the temporomandibular
joint (TMJ) can be affected, with consequences for mandibular growth and function. The aim of this study was to
evaluate the importance of longitudinal medical treatment and the burden of disease activity on the development of
temporomandibular condylar alterations as judged on panoramic radiographs.
Methods: The study was a retrospective evaluation of dental and medical records in consecutive JIA patients referred
to three specialist dental clinics in Sweden during an eight-year period. Data on the total pharmacological treatment
and disease activity were evaluated longitudinally from disease onset to the time of the panoramic examination, during
a median observation period of 2.5 years. The radiographs were analysed in terms of structural and shape alterations in
the condyles and judged dichotomously.
Results: Panoramic examinations were analysed in 158 patients from 266 referrals diagnosed with JIA. Condylar
alterations (shape or structural) were seen in 68 patients (43%). Patients with condylar alterations were more extensively
treated over time compared with those without condylar alterations. Powerful disease activity and/or potent
medication at any time during the course of the disease implied an increased risk of alterations.
Conclusions: Patients with JIA who require more intensive medication over time run the greatest risk of condylar
alterations. As yet, current medical programmes have not been specified for the TMJ and more knowledge in this area
is needed.
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Juvenile idiopathic arthritis (JIA) is an autoimmune,
heterogeneous disease with arthritis for at least six
weeks and onset before the age of 16 [1]. The disease
can express itself in many ways. The current classifica-
tion was proposed in 1994 by the International League
of Associations for Rheumatology (ILAR) [2,3].
It has been suggested that the temporomandibular joint
(TMJ) is one of the most frequently involved joints in JIA,* Correspondence: anna-lena.cedstromer@odontologi.gu.se
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article, unless otherwise stated.according to radiographic changes [4]. Swelling is seldom
seen and arthritis in the TMJ is often asymptomatic, as a
result of which the TMJ has been called “the forgotten
joint” in pediatric rheumatology [5]. The arthritis in the
TMJ thus evolves without subjective or clinical expres-
sions in many cases, which causes a delay in detection
[6,7], with consequences for mandibular growth and func-
tion [8]. A more precise clinical examination, combined
with imaging of the TMJ, is therefore important for the
detection of ongoing arthritis, as well as damage [9].
In the last few decades, magnetic resonance imaging
(MRI) has become the new standard for examining the
TMJs in children with JIA because it is an efficientntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
Figure 1 Panoramic radiograph on a patient with JIA with
example of common alteration, flattening, on the left TMJ.
Right side (H) is normal.
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Computed tomography (CT) is also a widespread tech-
nique and is often used in this context [7,13]. Arvidsson
et al. [13] found that 70% of JIA patients had TMJ involve-
ment on CT and MRI. MRI and CT are demanding,
expensive examinations.
In contrast, panoramic radiography is simple, inexpensive,
with relatively low radiation doses [14], commonly available
and requires no sedation in young children. It is often
performed prior to MRI or CT examinations in clinical
practice. Previous studies have found condylar lesions on
panoramic radiography in 17-78% of patients with JIA
[15-19]. There is thus a substantial spread in results relating
to the prevalence of condylar lesions among patients
with JIA, even when the same radiological technique
has been used.
The importance of current medication for TMJ arth-
ritis in JIA has also been examined. Radiological TMJ
abnormalities and the association with disease-modifying
anti-rheumatic drugs (DMARD), such as methotrexate
(MTX), are inconclusive. The results vary from no sig-
nificant effect to reduced TMJ alterations in patients
who medicate with MTX [17,19,20].
The degree of disease activity during its course could
be expected to be of importance for the development of
TMJ arthritis. Arvidsson et al. [19] found that TMJ
abnormalities were associated with reduced well-being
and more extensive involvement of other joints at the
final examination 27 years after onset. Billau et al. [18],
on the other hand, found no relationship between
condylar lesions and disease activity after a median dis-
ease duration of 2.96 years.
The way pharmacological treatment and disease acti-
vity influence the development of TMJ arthritis longitu-
dinally is unclear. The aim of this study was therefore to
evaluate how longitudinal medical treatment and the
burden of disease activity influence the development of
temporomandibular condylar alterations as judged on
panoramic radiographs.
Methods
All consecutive patients who fulfilled the ILAR criteria
for JIA [3] and were referred to three specialist dental
clinics in Sweden during an eight-year period were con-
sidered. Another inclusion criterion was that at least one
panoramic radiograph was performed during the study
period. One dentist (A-LC) screened the dental records
retrospectively and, supervised by a rheumatologist (LB),
collected data from the medical records at the attending
pediatric rheumatologic clinic.
Evaluations of the TMJs on the panoramic radiographs
were made by one dentist (A-LC) and one specialist in
oral radiology (MA) until consensus was reached. Both
were blinded to all other dental and medical information.The latest performed panoramic examination was used for
analysis. Seventy-two patients had only one panoramic
radiograph performed.
The panoramic radiographs were analysed in terms of
structural and shape alterations in the condyles. Struc-
tural changes included erosion (area with diminished
cortical density), sclerosis (increased cortical density)
and subchondral cysts. Changes in the shape of the con-
dyles included flattening (loss of smooth convexity) and
osteophytes (bony process on the anterior condyle). A
dichotomous judgement for each individual was given,
alteration or not in one or both condyles. An example of
common alterations is given in Figure 1. Moreover, any
toadstool appearance as described by Petrovski et al.
[21] in juvenile arthrosis and JIA was registered sepa-
rately. In this condition the condyle is flattened, elon-
gated and dorsally inclined. The condylar neck is
shortened or absent.
If one or both condyles were judged as “unreadable”,
the individual was excluded from further analysis. Most
of the radiographs, 86%, were digital and analysed on
monitors, one at the Department of Clinical Oral Physi-
ology at the Eastman Institute in Stockholm and one at
the Department of Oral and Maxillofacial Radiology,
University of Gothenburg. Analogous radiographs, 14%,
were analysed in an X-ray light box. Fifty randomly se-
lected cases were evaluated until consensus was reached
a second time after three weeks in order to establish the
reliability of the evaluation over time.
The total pharmacological treatment was evaluated
longitudinally from disease onset, established by the
rheumatologist, to the time of the panoramic examin-
ation. Medication with DMARDs, which included MTX,
and/or biologically modifying medications, including
tumour necrosis factor alpha inhibitors (TNF-alpha)
and/or corticosteroid injections in the TMJ, was denoted
“potent medication”. Fifteen patients received cortico-
steroid injections in the TMJ but only 4 without simul-
taneous DMARDs and therefore further analyses were
not possible. The use of “potent medication” for six
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evaluation of medical treatment was performed for each
six-month period during the first year after onset and
thereafter once every year until panoramic examination.
A period shorter than six months of medication or the
use of non-steroidal anti-inflammatory drugs (NSAID)
were not included.
Five disease activity groups yielding a modified version
of the European League Against Rheumatism (EULAR)
criteria [22] were used for the assessment of disease
activity. Disease activity was thus recorded as active dis-
ease = EU 1 (increasing number of active joints), stable =
EU 2 (unchanged number of active joints), inactive with
treatment = EU 3, inactive without treatment = EU 4 (no
disease activity and no treatment for less than two
years) and remission = EU 5 (no disease activity and no
treatment for more than two years). Disease activity,
defined as EU 1 and/or 2 for six months or more, was
denoted “active disease”. The first year after onset was
evaluated for each six-month period during the first
year and thereafter once every year. The time from dis-
ease onset to the date of the radiological examination
could thus be described as the number of periods with
“potent medication” and “active disease”. The number
of “medication periods” and “active disease periods” var-
ied from 0 to 8 and patients were followed for seven
years at most.
Statistics
In order to test the difference between condylar alterations
or not, the Mantel-Haenszel chi-square test was used. For
comparisons between condylar alterations or not in terms
of gender and age, Fisher’s exact test and the Mann-
Whitney u-test were used respectively. Spearman’s rank
correlation was used for the correlation analysis. Two-
tailed statistical analyses were performed at a significance
level of 5%, unless otherwise stated. Kappa statistics were
used to evaluate reliability over time. Bivariate logistic
regression analysis was used to establish the risk of
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Distribution of age at onset, disease duration, condylar alteration (shape or structurThe multicentre study was performed with the approval
of the Regional Ethical Review Board at the University of
Gothenburg, Gothenburg, Sweden (Dnr 342-07).
Results
A total of 266 patients with JIA were referred to the par-
ticipating specialist dental clinics during the eight-year
study period. Panoramic radiographs were exposed in
184 patients, 69%. Of the 184 patients, a total of 163 had
medical data from the same year as the panoramic
examination. Five radiographs were judged as “unread-
able” and 158 patients were consequently included in
this sub-study.
Five patients had missing medical data for one or two
periods between onset and the panoramic examination.
The reliability of the dichotomous radiological assess-
ments (structural and/or shape alteration or not) over
time was kappa = 0.68 (95% CI 0.56 to 0.80). This strength
of agreement is considered to be substantial [23].
The distribution of the 158 patients in ILAR categor-
ies, gender, age at onset, disease duration (time from
onset, as judged by the rheumatologist, to the panoramic
examination) radiographic condylar alterations (shape
and/or structural) and toadstool appearances is shown in
Table 1. Condylar alterations were found in 68 patients
(43%) and were not significantly associated with cat-
egory, gender, age at onset or duration. Sixty-seven pa-
tients had shape alterations and 25 structural alterations.
The prevalence of toadstool appearances was 12. Eight
of these also had condylar alterations.
Patients with or without condylar alterations (shape
and/or structural) are compared in terms of length of ac-
tive disease and burden of medication. The results are
given in Table 2. Any “potent medication” and number
of “medication periods” were more common in patients
with condylar alterations. Moreover, “EU 1 or potent
medication” and “EU 1 and potent medication” were sig-
nificantly more common among patients with condylar
alterations. The correlation between EU 1 and “potent
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Table 2 A total of 158 patients with JIA examined with panoramic radiographs
Total Condylar alterations No condylar alterations P
Total, n (% girls) 158 (73) 68 (78) 90 (70) 0.26
Duration, yrs, median (25/75th percentile) 2.5 (0.5/3.9) 2.8 (0.6/4.7) 2.3 (0.4/3.2) 0.21
“EU 1 any time”, n (%) 15 (9) 9 (13) 6 (7) 0.11
Number of “active disease periods”, median (25/75th percentile) 2.49 (1.0/3.0) 2.87 (1.0/4.0) 2.28 (1.0/3.0) 0.06
“Potent medication” any time, n (%) 75 (47) 41 (60) 34 (38) 0.01
Number of “medication periods”, median (25/75th percentile) 2.69 (1.0/4.0) 3.06 (1.0/4.0) 2.41 (1.0/3.0) 0.02
Both “MTX and TNF-alpha inhibitor” any time, n (%) 43 (27) 23 (34) 20 (22) 0.09
“EU 1 or potent medication” any time, n (%) 82 (52) 43 (63) 39 (43) 0.01
“EU 1 and potent medication” any time, n (%) 15 (10) 11 (16) 4 (4) 0.02
The association between condylar alterations, longitudinal disease activity and medication is presented. The bold values of column P is statistically significant (P =< 0.05).
Condylar alterations = shape or structural.
Duration = time from onset (yrs), as judged by the rheumatologist, to the panoramic examination.
“EU 1 any time” = active disease with increasing number of active joints any time for at least six months between onset and the panoramic examination.
Number of “active disease periods” = EU 1 and/or EU 2 (stable disease with unchanged number of active joints) for six months or more between onset and the
panoramic examination.
“Potent medication” =MTX and/or TNF-alpha inhibitor and/or corticosteroid injections in the TMJ any time for at least six months between onset and the
panoramic examination.
Number of “medication periods” = “potent medication” for six months or more between onset and the panoramic examination.
“MTX and TNF-alpha inhibitor any time” = intake of MTX and TNF-alpha any time for at least six months between onset and the panoramic examination.
“EU 1 and/or potent medication” any time = EU1 and/or potent medication for at least six months between onset and the panoramic examination.
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in the Figure 2. Patients with any “potent medication” ran
a significantly increased risk of condylar alterations
(P = 0.01). Increased numbers of “medication periods”
also increased the risk of condylar alterations (P = 0.02).
The risk of condylar alterations with a larger number of
“active disease periods” was not statistically significant,
only close to it (P = 0.06). Patients with “EU 1 or potent
medication” ran an increased risk of condylar alterations
(P = 0.01) and “EU 1 and potent medication” also in-
creased this risk (P = 0.02).
Discussion
This study collected data on TMJ condylar alterations
related to longitudinal medical background variables in a
comprehensive cohort of JIA patients referred to three
specialist dental clinics in Sweden over an eight-year
period. According to a National Care Program all JIA
patients at rheumatologic clinics should be referred to
specialist dental care but the percentage of JIA patients
that is actually referred is unknown. The radiographic-
ally examined group comprised 69% of the total cohort
of 266 patients. Condylar alterations, as judged on pano-
ramic radiographs, were more common in patients with
a heavier burden of longitudinal medication and conse-
quently more severe illness.
The reasons for performing a panoramic examination
in our study may have varied and it has previously been
shown that patients with active disease, EU 2, were
examined more often [24]. The fact that not all the
patients were examined with panoramic radiographyentails a possible bias. Missing medical data for solitary
periods for some patients are also a shortcoming. An-
other weak point is that panoramic radiography has lim-
ited diagnostic value for TMJ. It provides an overview of
the jaws, but only large condylar changes can be evalu-
ated with any confidence compared with more advanced
radiological techniques such as MRI, CT or Cone Beam
Computed Tomography (CBCT) [25,26]. The observa-
tional design also implies that the impact on the con-
dyles in the event of no medication in active disease is
unknown. A modified version of EULAR was used to
describe disease activity in this study, but there are other
ways of categorizing it. One limitation of EULAR is that
the disease activity is only measured on active joints
compared, for example, with JADAS 27, where the sums
of components are compounded [27].
Condylar radiographic alterations were found in 43%
of the examined patients. Studies using the panoramic
radiographic technique have reported different results in
terms of TMJ condylar alterations, 17-78%, and the size
of the studied populations has also varied from 97 to
249 JIA patients [15-19]. Arvidsson et al. [19] reported
that TMJ abnormalities in patients with JIA, found in
panoramics, increased from childhood to adulthood
from 42% to 82% in a cohort followed for 27 years.
Different scoring systems to grade the involvement of
TMJs in JIA on panoramic examinations have been ap-
plied. Twilt et al. [9,17] used a grading system developed
for adult rheumatoid arthritis [28]. Billau et al. [18] used
a “condylar damage score” from small cortical bone ero-
sion to the complete absence of a condylar head. Pedersen
Figure 2 Results of bivariate logistic regression on the risk of condylar alterations on panoramic radiographs in patients with JIA
(n = 158) presented in odds ratios (OR) (95% Cl) and P-values. The distribution of duration (time from onset to panoramic examination, yrs),
“EU 1 any time” (active disease with increasing number of active joints any time for at least six months between onset and the panoramic
examination), number of “active disease periods” (EU1 and/or EU2 (stable disease with unchanged number of active joints) for six months or
more between onset and the panoramic examination), “potent medication” any time (MTX and/or TNF-alpha inhibitor and/or corticosteroid injections
in the TMJ for at least six months between onset and the panoramic examination), number of “medication periods” (potent medication for six months
or more between onset and the panoramic examination), “MTX+ TNF-alpha inhibitor anytime” (intake of MTX and TNF-alpha any time for at least six
months between onset and the panoramic examination). “EU 1 or potent medication” any time (EU 1 or potent medication for at least six months
between onset and the panoramic examination) and “EU 1 and potent medication” any time (EU 1 and potent medication for at least six months
between onset and the panoramic examination) are given.
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abnormalities to the total destruction of the condyle.
Arvidsson et al. [19] graded the condylar deformity from 0
to 3. The divergent results for condylar alterations are
most probably due to different scoring systems and patient
populations. To simplify the categorization, condylar alter-
ations were only registered dichotomously in this study.
The importance of longitudinal medication for avoid-
ing TMJ arthritis in JIA, evaluated on panoramic radio-
graphs, has previously been studied. Arvidsson et al. [19]
found no significant difference in TMJ abnormalities be-
tween patients with or without previous MTX treatment
and/or the use of biological drugs studied for a mean
duration of 3.2 years. Twilt et al. [17] found TMJ
involvement in 68% of the patients with previous or
present DMARD (not MTX) as compared to 29% in pa-
tients with previous or present immunosuppressive ther-
apy (corticosteroids and MTX) with a mean duration of
4.9 years. The difference between the groups was not
discussed in more detail. Ince et al. [20], on the other
hand, found significantly more frequent and more severe
condylar involvement in JIA patients without MTX atthe time of the panoramic examination. The observation
period was eight years for the non-MTX group and 6.9
years for the MTX group. It was concluded that MTX
therapy may minimise the TMJ destruction, but longitu-
dinal studies would provide more definitive information.
As yet, there is not enough knowledge when it comes
to the optimal therapy for avoiding or treating TMJ
arthritis. TNF-alpha inhibitors are used in approximately
20-25% of children with JIA in Sweden [29]. A review
concluded that some children with JIA develop TMJ
arthritis despite TNF-alpha inhibitors [4]. The authors
suggested that there is a need for more longitudinal
studies to evaluate the effect on the TMJs. A high per-
centage of children with JIA may have TMJ arthritis
whether or not they are on systemic DMARD therapy.
[30]. Studies comparing TNF-alpha with MTX treatment
have not been performed [31]. In this cohort, some pa-
tients had TNF-alpha inhibitors for only a short period
and it is therefore difficult to draw any conclusions
about the effect on TMJ arthritis. Although not statisti-
cally significant in this study the combination of TNF-
alpha inhibitors and MTX may have a protective effect
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be effective [32] but this therapy alone was very un-
common in this cohort.
In a review of randomized controlled trials in JIA on
treatment with biological agents, no conclusions about
efficacy could be drawn, because of the small number of
patients and differences in design between the trials
[33]. Many children with JIA have periods of active
disease despite current medical programmes. Vidqvist
et al. [34] reported several inflamed joints in the last
year in 58% of patients with JIA with a median age of 19
years in spite of medication. The present study confirms
their result. The number of “active disease periods”
correlated with periods of heavier medical treatment
and, in our study, periods of heavier treatment were
significantly associated with condylar alterations.
Conclusion
To summarize, TMJ damage, evaluated as condylar alter-
ations on panoramic radiographs, was fairly common in
our cohort of patients with JIA. Alterations have been
found to correlate with synovitis [35]. The unique ana-
tomy of the TMJ with a thin layer of fibrocartilage at the
surface of the condylar head and the biochemical com-
position makes it susceptible to damage caused by arth-
ritis [4]. The results suggest, within the limits of this
observational study, that active disease appears to in-
crease the risk of alterations to the TMJs despite medica-
tion. As yet, current medical programmes have not been
specified for the TMJ and more knowledge is needed in
this area. Longer follow-up studies and further prospect-
ive studies with the emphasis on the progress of TMJ
arthritis are necessary.
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